Popular on Amzeal
- Personal Prompt Builder™ App Launches With Free Prompt Generation for a Quick Start - 195
- Clearnetworx Deploys netElastic vBNG, CGNAT And netVision To Power Fiber Expansion Across Colorado's Western Slope - 179
- America's Hometown Thanksgiving Parade in Plymouth, MA, on Saturday, November 21, 2026 - 173
- Immerse Yourself in the Historic Tochigi Autumn Festival, Celebrated Every Two Years Since 1874 - 170
- HLN Consulting Names Lilly Kan as Its First Chief Executive Officer - 154
- BitTitan Accelerates Large-Scale Document Migrations with MigrationWiz - 152
- Self-Published Dad's Santa Book Finally Found After 3 Years on Amazon - 144
- XImagineAI Upgrades Its Multi-Model AI Video Generator for Image to Video and Text to Video - 141
- 2026 Governor's Celebration of Innovation Future Innovators and Teacher of the Year Awardees Announced by Arizona Technology Council and Arizona Co - 121
- Creole101 Launches Multilingual Dictionary App with 50,000+ Entries, Vocabulary Games and Haitian Cultural Resources - 119
Similar on Amzeal
- TCA VG: 2025 Funding Climbs to $9M across 43 Companies; Cumulative Returns Reach 5.3 MOIC & 22% IRR
- Commercial Sales Launch Following FDA Approval; National Sales Force Now in Action as January Shipments and Major Market Opportunity Take Shape
- Contracting Resources Group Named a 2027 Elev8 GovCon Honoree by OrangeSlices
- Qscription Technologies Welcomes Joanna Krause, MD, MRMD to Its Clinical Advisory Board
- New Omega-3 Fish Oil Under NIH Investigation: What Makes It Different From EPA and DHA?
- OncoBeta Introduces Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Cancer Hospital of Thessaloniki
- New Patient Data Show REQORSA® Activating Cellular Repair Pathways as Roche Collaboration Advances Precision Lung Cancer Strategy for Genprex, Inc
- Shiokly Launches Online Marketplace to Help Singapore Home-Based Businesses Sell More, With First Product Listed Free
- New TROP2 Research Breakthrough Strengthens REQORSA® Gene Therapy Story as Roche Collaboration Advances Precision Lung Cancer Treatment: Genprex, Inc
- FDA Approval; Major Milestone for Preservative-Free Ketamine Ahead of FDA Goal Date for Treatment of Suicidal Depression by NRx Pharmaceuticals, Inc
83bar publishes eight new reports from its Patient Activation market research
Amzeal News/10333075
- Market research insights from recent patient activation tests using the 83bar integrated digital health platform
- Highlights from eight important medical categories, including depression, migraine, and NASH
- Implications of findings for pharma brands, medical devices, and clinical trial recruitment
- Highlights from eight important medical categories, including depression, migraine, and NASH
- Implications of findings for pharma brands, medical devices, and clinical trial recruitment
AUSTIN, Texas - Amzeal -- 83bar, LLC has published a series of market research reports from its Patient Activation programs. The reports are now available with key findings and conclusions for eight important medical categories: cryotherapy, depression, melanoma, migraine, NASH, nerve pain, pediatric general anxiety disorder, and SUI.
83bar generated the data in the reports using its fully integrated digital health technology and clinical contact platform. The company already has achieved significant results with its process for provider networks, commercial clients, and clinical trial sponsors. These reports demonstrate the value of the approach in market research applications.
According to Bob Baurys, CEO of 83bar, "To make the most informed decisions, whether you're a healthcare provider or medical marketer, you need to know how the prospective patients will respond, which consumer segments will drive growth, and how messages might shift across categories. This series can guide your strategy with real-world, data-driven market research insights."
Alex Hilderbrand, vice president of patient activation & strategy at 83bar, directed the execution of the market research, as well as the compilation of the data analysis. He says, "Taken together, these reports offer a perspective on medical market trends and evolving healthcare consumer behaviors, supported by our proprietary system." Hilderbrand adds that studies reflected a total of more than 1,000 respondents across the eight markets.
More on Amzeal News
Highlights from the 83bar Patient Activation market research reports:
More on Amzeal News
For more information and to download any of these reports, visit our 83bar Market Research page.
The team at 83bar also offers custom research services providing focused, comprehensive, testing tailored to individual market needs and client strategies.
About 83bar, LLC
83bar, LLC, headquartered in Austin, Texas, is the leading patient activation marketing agency. 83bar has developed a system implemented by nearly three dozen name brands in health, medical, technology, and devices. The company has a database of more than 850,000 patient engagements over the past three years. Its four-step activation process is integrated to LOCATE prospective patients through risk assessment and health surveys; EDUCATE them to offer solutions and help them make informed decisions; NAVIGATE patients to action by appointment scheduling or service fulfillment; and through comprehensive follow-up, convert these patients to ADVOCATE on behalf of improved treatment and health care. Contact at www.go83bar.com
83bar generated the data in the reports using its fully integrated digital health technology and clinical contact platform. The company already has achieved significant results with its process for provider networks, commercial clients, and clinical trial sponsors. These reports demonstrate the value of the approach in market research applications.
According to Bob Baurys, CEO of 83bar, "To make the most informed decisions, whether you're a healthcare provider or medical marketer, you need to know how the prospective patients will respond, which consumer segments will drive growth, and how messages might shift across categories. This series can guide your strategy with real-world, data-driven market research insights."
Alex Hilderbrand, vice president of patient activation & strategy at 83bar, directed the execution of the market research, as well as the compilation of the data analysis. He says, "Taken together, these reports offer a perspective on medical market trends and evolving healthcare consumer behaviors, supported by our proprietary system." Hilderbrand adds that studies reflected a total of more than 1,000 respondents across the eight markets.
More on Amzeal News
- UpgradeX Announces Black Friday Offer on GoodWe ESA 27kWh All-in-One Battery System
- Parental control app for iPhone SimpleSentinel launches: one tap pauses phone, clock stays locked
- Joshua Grasmick Takes World's No. 1 Spot in AI Reasoning and Retrieval, Surpassing NVIDIA, Leading
- The Fifth Annual "Bamboo Lantern Festival" to Illuminate Tokyo Mizumachi and Sumida River Walk®
- Iglesia.com Positioned in Multimillion-Dollar Domain Market with $10 Million Asking Price
Highlights from the 83bar Patient Activation market research reports:
- Among Cryotherapy patients, there is significant interest in reducing pain reduction, improving athletic performance, and boosting metabolism. In addition, the report reveals an underlying concern with chronic depression or anxiety.
- The Depression study offers a profile of patients frustrated with current treatments. Almost all had difficulty attending work or school. Fully half have tried 4+ medications; yet 49% are not currently under care of psychiatrist. While majority were 18-50, one-third were 50+, revealing a significant opportunity with seniors.
- Melanoma patients who notice changes in skin appearance still may not connect to risk. Nearly 9 out of 10 were not diagnosed; specifically, one-third notice mole with uneven borders, but another one-third did not recognize signs. Half of respondents self-described as "analytical."
- The Migraine report shows more than 74% have been suffering for more than five years, and over 77% expressed dissatisfaction with their current treatment plan. Overwhelmingly, the majority of respondents are interested in migraine treatment options and clinical studies
- The NASH market test verified the ability of the 83bar method to attract hard-to-find patient prospects with pre-qualified medical conditions aligned to protocol inclusion and exclusion criteria for nonalcoholic steatohepatitis
- In the Nerve Pain survey, more than 6 out of 10 of those with deficit in chest and breast experience shooting pain in chest, armpit, or arm. Almost half have been experiencing symptoms more than 3 years, with significant impact on family and work quality of life.
- Results in Pediatric General Anxiety Disorder underscored children experiencing worries about school, friends, or activities, as well as lack of concentration and frequent stomach or headaches. It revealed that while 68% reported quality of life being "extremely" impacted, a significant 72% were not taking medication. Nearly a third of patients had been diagnosed by primary care or pediatricians other than a psychiatrist.
- In Stress Urinary Incontinence, the survey profiled patients frustrated with the impact on daily living. More than half are long-time sufferers; yet one-third have experienced symptoms only 1-3 years. It also showed a high incidence of lower back pain.
More on Amzeal News
- TCA VG: 2025 Funding Climbs to $9M across 43 Companies; Cumulative Returns Reach 5.3 MOIC & 22% IRR
- Searching for the Next LBE Creator: CalArts Launches First-Ever D.R.E.A.M.S. Pitch Competition
- Integris Composites Joins International Sea Power Conference Aboard HMS Prince of Wales
- Electronic Office Systems Named ENX Magazine Elite Dealer for 26th Consecutive Year
- Commercial Sales Launch Following FDA Approval; National Sales Force Now in Action as January Shipments and Major Market Opportunity Take Shape
For more information and to download any of these reports, visit our 83bar Market Research page.
The team at 83bar also offers custom research services providing focused, comprehensive, testing tailored to individual market needs and client strategies.
About 83bar, LLC
83bar, LLC, headquartered in Austin, Texas, is the leading patient activation marketing agency. 83bar has developed a system implemented by nearly three dozen name brands in health, medical, technology, and devices. The company has a database of more than 850,000 patient engagements over the past three years. Its four-step activation process is integrated to LOCATE prospective patients through risk assessment and health surveys; EDUCATE them to offer solutions and help them make informed decisions; NAVIGATE patients to action by appointment scheduling or service fulfillment; and through comprehensive follow-up, convert these patients to ADVOCATE on behalf of improved treatment and health care. Contact at www.go83bar.com
Source: 83bar, LLC
0 Comments
Latest on Amzeal News
- Network Services Group Outlines Ways It Can Help Ann Arbor Businesses with Tech Support
- Christmas Beats Summer in Paris: Travel Photoshoots Peak on Dec. 30
- Qscription Technologies Welcomes Joanna Krause, MD, MRMD to Its Clinical Advisory Board
- Jamie Foxx's SKVLK Fest Sets the Record Straight on Stabbing Reports Following Star-Studded Celebration
- Andrew Balzano Releases One of My Life's Passions: Classics and Mysteries, a Fan's Guide to Great Mysteries Worth Rewatching
- Arizona Technology Council Elects Raytheon and Western Alliance Bank Leaders to Board of Directors
- The 4th Annual Newark Summit for Economic Development, Placemaking & Innovation Returns on December 8th
- Australia's Data Centre Power Demand Surges as Nexorumi Highlights AI Infrastructure Challenges
- Romanian Software Company ASSIST Software Ranks Second Nationally Among Large Enterprises in Its Category
- RonaldReeves.com Launches Comprehensive Hub of Free Online Tools and Calculators
- Misophonia Foundation Releases Free World of Warcraft Addon To Block Visual Triggers
- The Big Deal Shop Catalog Launch
- HIRO Ostomy Belt Launch by Richard O'Hamill
- New Omega-3 Fish Oil Under NIH Investigation: What Makes It Different From EPA and DHA?
- Technical Brief Examines Enterprise Integration Challenges as AI Agent Platforms Expand
- How Melbourne's Changing Climate Impacts Solar Battery Efficiency, Performance and Lifespan
- OncoBeta Introduces Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Cancer Hospital of Thessaloniki
- Haptic Zones Zone Playground Lets Anyone Draw a Zone and Watch Compliance Code Appear
- Nexorumi Pty Ltd Launches in Australia with Focus on AI Infrastructure
- Brian G. Miller Co., LLC Receives Tier 1 Ranking in the 2027 Edition of Best Law Firms®


